FDA to allow emergency use of Moderna's COVID vaccine

FDA to allow emergency use of Moderna's COVID vaccine
  • Clock-gray 10:32
  • calendar-gray 18 December 2020

United States Food and Drug Administration (FDA) has chosen to grant Emergency Use Authorization (EUA) to the coronavirus vaccine developed by Moderna Inc., The Financial Times reported citing people close to the process, APA reports citing Teletrader.

The FDA emergency approval would pave the way for doses of the second inoculation against the virus to be distributed across the country as the agency had already authorized the vaccine developed by Pfizer Inc. and BioNTech SE last week.

FDA Commissioner Stephen Hahn has vowed the agency will work "rapidly" toward the finalization and issuance of the authorization after a team of experts recommended the candidate be authorized.

apa-logo-mini

Other news